Stay updated on Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision changed from v3.4.0 to v3.4.1 in the page metadata, with no changes to the study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:09:42.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page adds a visible 'Show glossary' option and updates labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with a new revision indicator 'Revision: v3.4.0'; it also removes the lowercase variants 'met QC Criteria' and 'No FEAR Act data' as well as the older 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T21:46:31.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    This is a minor revision update (from v3.3.3 to v3.3.4) and does not alter any study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:25:42.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Added a general 'Locations' section and explicitly listed Massachusetts as a location; removed the previously listed 'Massachusetts Locations' entry. Updated the site footer by removing the 'HHS Vulnerability Disclosure' link and changed the page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:30:56.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; no other content changes to the study details were observed.
    Difference
    0.1%
    Check dated 2025-11-24T21:31:52.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Removed the banner about a lapse in government funding and potential delays in updates. This site-wide notice is not part of the study details.
    Difference
    0.4%
    Check dated 2025-11-17T19:54:57.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.